Aurinia Pharmaceuticals
AUPH
#5316
Rank
C$1.66 B
Marketcap
$11.60
Share price
3.49%
Change (1 day)
9.14%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -C$19.82 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.22 Billion. In 2023 the company made an earning of -C$0.11 Billion, an increase over its 2022 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$19.82 Million-81.68%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.27 Billion61.9%
2020 -C$0.17 Billion-9.73%
2019 -C$0.18 Billion92.65%
2018 -C$92.95 Million36.39%
2017 -C$68.15 Million106.29%
2016 -C$33.04 Million-15.4%
2015 -C$39.05 Million65.84%
2014 -C$23.55 Million129.82%
2013 -C$10.25 Million-26.6%
2012 -C$13.96 Million
2010 -C$7.91 Million-39.22%
2009 -C$13.01 Million-43.78%
2008 -C$23.13 Million-53.19%
2007 -C$49.42 Million42.97%
2006 -C$34.57 Million-23.03%
2005 -C$44.91 Million36.1%
2004 -C$33 Million172.57%
2003 -C$12.11 Million484.61%
2002 -C$2.08 Million
2000 -C$9.84 Million453.81%
1999 -C$1.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$7.19 B-32,918.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$7.95 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$32.04 Million 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA